Related references
Note: Only part of the references are listed.Potential use of transgenic domestic pigs expressing recombinant human erythropoietin in diabetes translation research
Sun-Young Baek et al.
ANIMAL CELLS AND SYSTEMS (2019)
Investigation of the pronounced erythropoietin-induced reduction in hyperglycemia in type 1-like diabetic rats
Shu-Chun Kuo et al.
ENDOCRINE JOURNAL (2018)
Erythropoietin administration is associated with improved T-cell properties in patients with myelodysplastic syndromes
Naamit Deshet-Unger et al.
LEUKEMIA RESEARCH (2017)
Chronic erythropoietin treatment improves diet-induced glucose intolerance in rats
Corinne Caillaud et al.
JOURNAL OF ENDOCRINOLOGY (2015)
Erythropoietin (EPO) Protects Against High Glucose-Induced Apoptosis in Retinal Ganglional Cells
Yunxiao Wang et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
Erythropoietin Signaling: A Novel Regulator of White Adipose Tissue Inflammation During Diet-Induced Obesity
Mawadda Alnaeeli et al.
DIABETES (2014)
PPARα and Sirt1 Mediate Erythropoietin Action in Increasing Metabolic Activity and Browning of White Adipocytes to Protect Against Obesity and Metabolic Disorders
Li Wang et al.
DIABETES (2013)
In Vivo Knockdown of Adipocyte Erythropoietin Receptor Does Not Alter Glucose or Energy Homeostasis
Cynthia T. Luk et al.
ENDOCRINOLOGY (2013)
Erythropoietin treatment is associated with an augmented immune response to the influenza vaccine in hematologic patients
Howard S. Oster et al.
EXPERIMENTAL HEMATOLOGY (2013)
Effects of Erythropoietin on Glucose Metabolism
E. Mikolas et al.
HORMONE AND METABOLIC RESEARCH (2012)
Erythropoietin: The swinging pendulum
Howard S. Oster et al.
LEUKEMIA RESEARCH (2012)
American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer
J. Douglas Rizzo et al.
BLOOD (2010)
Macrophages as novel target cells for erythropoietin
Lilach Lifshitz et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Erythropoietin treatment leads to reduced blood glucose levels and body mass: insights from murine models
Odelia Katz et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Erythropoietin protects against diabetes through direct effects on pancreatic β cells
Diana Choi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Non-erythroid activities of erythropoietin: Functional effects on murine dendritic cells
Lilach Lifshitz et al.
MOLECULAR IMMUNOLOGY (2009)
Update on Erythropoiesis-Stimulating Agents and Clinical Trials in Oncology
Matti Aapro et al.
ONCOLOGIST (2009)
Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease?
Sara Prutchi-Sagiv et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Inappropriately low erythropoietin response for the degree of anemia in patients with noninsulin-dependent diabetes mellitus
A Symeonidis et al.
ANNALS OF HEMATOLOGY (2006)
Protein tyrosine phosphatase 1B participates in the down-regulation of erythropoietin receptor signalling
J Cohen et al.
BIOCHEMICAL JOURNAL (2004)
The comparison of insulin sensitivity in non-diabetic hemodialysis patients treated with and without recombinant human erythropoietin
A Tuzcu et al.
HORMONE AND METABOLIC RESEARCH (2004)
Human, nonhuman primate, and rat pancreatic islets express erythropoietin receptors
ES Fenjves et al.
TRANSPLANTATION (2003)
New clinical practice guidelines for chronic kidney disease: A framework for K/DOQI
SS Patel et al.
SEMINARS IN NEPHROLOGY (2002)
Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models
M Mittelman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Effect of short-term rHuEPO treatment on insulin resistance in haemodialysis patients
S Spaia et al.
NEPHRON (2000)
Share Paper
